Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Parsons

Showing results (511-520 of 573) with videos related to

Pageof 58
Sort By:
International Journal of Stroke : Official Journal of the International Stroke Society|April 10, 2019
Applicability of ENCHANTED trial results to current acute ischemic stroke patients eligible for intravenous thrombolysis in England and Wales: Comparison with the Sentinel Stroke National Audit Programme registryThompson G Robinson, Benjamin D Bray, Lizz Paley, et al.
JAMA Neurology|October 4, 2017
Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke: Secondary Analysis of the ENCHANTED Randomized Clinical TrialXia Wang, Thompson G Robinson, Tsong-Hai Lee, et al.
Lancet (London, England)|May 18, 2010
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trialsKennedy R Lees, Erich Bluhmki, Rüdiger von Kummer, et al.
Frontiers in Neurology|November 23, 2020
Plasmin Generation Potential and Recanalization in Acute Ischaemic Stroke; an Observational Cohort Study of Stroke Biobank SamplesThomas Lillicrap, Charithani B Keragala, Dominik F Draxler, et al.
Stroke|September 10, 2025
Efficacy of Tenecteplase in Large Vessel Occlusion Stroke Within 24 Hours of Symptom Onset: The ETERNAL-LVO Randomized Controlled TrialVignan Yogendrakumar, Bruce C V Campbell, Leonid Churilov, et al.
Frontiers in Neurology|May 10, 2021
The Incidence of Stroke in Indigenous Populations of Countries With a Very High Human Development Index: A Systematic Review ProtocolAnna H Balabanski, Angela Dos Santos, John A Woods, et al.
The New England Journal of Medicine|June 17, 2024
Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without ThrombectomyYunyun Xiong, Bruce C V Campbell, Lee H Schwamm, et al.
Stroke|March 30, 2026
Cerebral Edema in Patients With Large Ischemic Core After Thrombectomy: A Secondary Analysis of SELECT2 Randomized TrialFelix Ng, Vignan Yogendrakumar, Hannah Johns, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|April 3, 2015
Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatmentYining Huang, Vijay K Sharma, Thompson Robinson, et al.
Stroke|April 14, 2016
Acute Stroke Imaging Research Roadmap III Imaging Selection and Outcomes in Acute Stroke Reperfusion Clinical Trials: Consensus Recommendations and Further Research PrioritiesSteven J Warach, Marie Luby, Gregory W Albers, et al.
Pageof 58

Showing results (511-520 of 573) with videos related to

Sort By:
Pageof 58
International Journal of Stroke : Official Journal of the International Stroke Society|April 10, 2019
Applicability of ENCHANTED trial results to current acute ischemic stroke patients eligible for intravenous thrombolysis in England and Wales: Comparison with the Sentinel Stroke National Audit Programme registryThompson G Robinson, Benjamin D Bray, Lizz Paley, et al.
JAMA Neurology|October 4, 2017
Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke: Secondary Analysis of the ENCHANTED Randomized Clinical TrialXia Wang, Thompson G Robinson, Tsong-Hai Lee, et al.
Lancet (London, England)|May 18, 2010
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trialsKennedy R Lees, Erich Bluhmki, Rüdiger von Kummer, et al.
Frontiers in Neurology|November 23, 2020
Plasmin Generation Potential and Recanalization in Acute Ischaemic Stroke; an Observational Cohort Study of Stroke Biobank SamplesThomas Lillicrap, Charithani B Keragala, Dominik F Draxler, et al.
Stroke|September 10, 2025
Efficacy of Tenecteplase in Large Vessel Occlusion Stroke Within 24 Hours of Symptom Onset: The ETERNAL-LVO Randomized Controlled TrialVignan Yogendrakumar, Bruce C V Campbell, Leonid Churilov, et al.
Frontiers in Neurology|May 10, 2021
The Incidence of Stroke in Indigenous Populations of Countries With a Very High Human Development Index: A Systematic Review ProtocolAnna H Balabanski, Angela Dos Santos, John A Woods, et al.
The New England Journal of Medicine|June 17, 2024
Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without ThrombectomyYunyun Xiong, Bruce C V Campbell, Lee H Schwamm, et al.
Stroke|March 30, 2026
Cerebral Edema in Patients With Large Ischemic Core After Thrombectomy: A Secondary Analysis of SELECT2 Randomized TrialFelix Ng, Vignan Yogendrakumar, Hannah Johns, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|April 3, 2015
Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatmentYining Huang, Vijay K Sharma, Thompson Robinson, et al.
Stroke|April 14, 2016
Acute Stroke Imaging Research Roadmap III Imaging Selection and Outcomes in Acute Stroke Reperfusion Clinical Trials: Consensus Recommendations and Further Research PrioritiesSteven J Warach, Marie Luby, Gregory W Albers, et al.
Pageof 58